Valeo Pharma (VPH) Competitors C$0.04 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlines VPH vs. NRTH, MRV, WLLW, CTX, FLWR, VM, KHRN, MPH, AH, and HVTShould you be buying Valeo Pharma stock or one of its competitors? The main competitors of Valeo Pharma include 48North Cannabis (NRTH), Nuvo Pharmaceuticals (MRV), Willow Biosciences (WLLW), Crescita Therapeutics (CTX), Flowr (FLWR), Voyageur Pharmaceuticals (VM), Khiron Life Sciences (KHRN), Medicure (MPH), Aleafia Health (AH), and Harvest One Cannabis (HVT). These companies are all part of the "drug manufacturers - specialty & generic" industry. Valeo Pharma vs. 48North Cannabis Nuvo Pharmaceuticals Willow Biosciences Crescita Therapeutics Flowr Voyageur Pharmaceuticals Khiron Life Sciences Medicure Aleafia Health Harvest One Cannabis Valeo Pharma (TSE:VPH) and 48North Cannabis (CVE:NRTH) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, community ranking, analyst recommendations and profitability. Do insiders & institutionals believe in VPH or NRTH? 7.2% of Valeo Pharma shares are held by institutional investors. 47.1% of Valeo Pharma shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media prefer VPH or NRTH? In the previous week, 48North Cannabis had 3 more articles in the media than Valeo Pharma. MarketBeat recorded 4 mentions for 48North Cannabis and 1 mentions for Valeo Pharma. 48North Cannabis' average media sentiment score of 0.20 beat Valeo Pharma's score of -1.30 indicating that 48North Cannabis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Valeo Pharma 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Negative 48North Cannabis 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable valuation and earnings, VPH or NRTH? Valeo Pharma has higher revenue and earnings than 48North Cannabis. 48North Cannabis is trading at a lower price-to-earnings ratio than Valeo Pharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioValeo PharmaC$53.38M0.08-C$32.12M-C$0.37-0.1248North CannabisC$18.90M0.83-C$52.46M-C$0.23-0.30 Do analysts recommend VPH or NRTH? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Valeo Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A48North Cannabis 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Is VPH or NRTH more profitable? 48North Cannabis has a net margin of 0.00% compared to Valeo Pharma's net margin of -60.18%. Company Net Margins Return on Equity Return on Assets Valeo Pharma-60.18% N/A -26.07% 48North Cannabis N/A N/A N/A Does the MarketBeat Community prefer VPH or NRTH? 48North Cannabis received 11 more outperform votes than Valeo Pharma when rated by MarketBeat users. However, 100.00% of users gave Valeo Pharma an outperform vote while only 75.00% of users gave 48North Cannabis an outperform vote. CompanyUnderperformOutperformValeo PharmaOutperform Votes1100.00% Underperform VotesNo Votes48North CannabisOutperform Votes1275.00% Underperform Votes425.00% Summary48North Cannabis beats Valeo Pharma on 7 of the 13 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get Valeo Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for VPH and its competitors with MarketBeat's FREE daily newsletter. Email Address VPH vs. The Competition Export to ExcelMetricValeo PharmaDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$4.44MC$1.22BC$5.40BC$5.94BDividend YieldN/A3.13%5.15%5.37%P/E Ratio-0.12110.73113.7625.87Price / Sales0.083,426.271,483.041,515.70Price / CashN/A10.1939.7181.06Price / Book-0.073.174.663.11Net Income-C$32.12MC$155.16MC$119.06MC$292.76M7 Day PerformanceN/A-0.07%0.79%-1.65%1 Month PerformanceN/A-0.75%5.65%2.32%1 Year PerformanceN/A100.86%36.80%45.73% Valeo Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VPHValeo PharmaN/AC$0.05flatN/AN/AC$4.44MC$53.38M-0.12100News CoverageNegative NewsNRTH48North CannabisN/AC$0.07-6.7%N/A+0.0%C$15.76MC$18.90M-0.3047MRVNuvo PharmaceuticalsN/AN/AN/AN/AC$15.38MC$72.42M-19.29N/AWLLWWillow BiosciencesN/AC$0.10flatN/A+12.5%C$13.70MC$1.84M-1.5819CTXCrescita TherapeuticsN/AC$0.60-3.2%N/A-3.3%C$11.63MC$16.84M-4.0062News CoverageFLWRFlowrN/AC$0.03flatN/A+0.0%C$10.66MC$12.92M-0.12186News CoverageVMVoyageur PharmaceuticalsN/AC$0.07+7.7%N/A+55.6%C$9.76MN/A-7.00N/AGap UpKHRNKhiron Life SciencesN/AC$0.04flatN/A+0.0%C$9.30MC$16.14M-0.24N/AGap UpMPHMedicureN/AC$0.88-3.3%N/A-43.2%C$9.19MC$20.93M-3.52N/AGap DownAHAleafia HealthN/AN/AN/AN/AC$8.07MC$42.85M-0.22158HVTHarvest One CannabisN/AC$0.03flatN/A+0.0%C$6.32MC$8.39M-0.462,840News CoverageNegative News Related Companies and Tools Related Companies 48North Cannabis Alternatives Nuvo Pharmaceuticals Alternatives Willow Biosciences Alternatives Crescita Therapeutics Alternatives Flowr Alternatives Voyageur Pharmaceuticals Alternatives Khiron Life Sciences Alternatives Medicure Alternatives Aleafia Health Alternatives Harvest One Cannabis Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:VPH) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Valeo Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Valeo Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
